Champion Iron Ltd (CIA)
Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 2.270 |
|---|---|
| 52-week range | 2.270 – 6.109 |
| Return, 1 month / 3 months | −28.4% / −41.3% |
| Return, 1 year / 3 years | −45.5% / −51.3% |
| Trend | Below its 200-day average |
| RSI (14) | 13 |
| Volatility (1 year) | 38.8% |
| Worst drawdown (1 year) | -62.5% |
| Average daily value traded | 1.78M CAD |
| Dividend yield | 10.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Champion Iron Ltd is a mining company based in Canada that produces iron ore concentrate. Its operations centre on the Bloom Lake mine in the Labrador Trough region of Quebec, where it extracts and processes ore into a high-grade concentrate. The company ships this concentrate to steel producers and trading markets, mainly in Asia and Europe, supplying raw material for steelmaking. Its business spans mining, processing and rail transport of ore from its Quebec operations to port.
On this site Champion Iron Ltd appears as a stock on the Toronto Exchange (Canada), code CIA, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Champion Iron Ltd (CIA) trades on the Toronto Exchange in Canada. It last closed at CAD 2.270 on 19 October 2026.
Its price-based Market X-Ray is 26 out of 100 (a weak price profile), ranking 729 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 45.5% and over the last three months it fell 41.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 4 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -48.1% | ||
| From 52-week high | -62.5% | ||
| Momentum | 7 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -41.3% | ||
| 6-month return | -53.9% | ||
| 12-month return, skipping the last month | -23.9% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 38.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -62.5% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.78M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 10.1% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −17.8% |
|---|---|
| 1 month | −28.4% |
| 3 months | −41.3% |
| 6 months | −53.9% |
| 1 year | −45.5% |
| 3 years | −51.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 3.202 / 4.370 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.099 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Jun 2026 | CAD 0.0200 |
| 12 Nov 2025 | CAD 0.1000 |
| 11 Nov 2025 | CAD 0.1100 |
| 13 Jun 2025 | CAD 0.1000 |
| 12 Nov 2024 | CAD 0.1000 |
| 14 Jun 2024 | CAD 0.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.